ARJOBS Stock Overview
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Arjo AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr41.13 |
| 52 Week High | kr48.40 |
| 52 Week Low | kr38.29 |
| Beta | 0.29 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -36.43% |
| 5 Year Change | 19.56% |
| Change since IPO | 65.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARJOBS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 1.1% |
| 1Y | n/a | -8.9% | 6.8% |
Return vs Industry: Insufficient data to determine how ARJOBS performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how ARJOBS performed against the UK Market.
Price Volatility
| ARJOBS volatility | |
|---|---|
| ARJOBS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: ARJOBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ARJOBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 6,667 | Joacim Lindoff | www.arjo.com/int/ |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
| ARJOBS fundamental statistics | |
|---|---|
| Market cap | kr14.20b |
| Earnings (TTM) | kr480.00m |
| Revenue (TTM) | kr10.98b |
29.6x
P/E Ratio1.3x
P/S RatioIs ARJOBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARJOBS income statement (TTM) | |
|---|---|
| Revenue | kr10.98b |
| Cost of Revenue | kr6.24b |
| Gross Profit | kr4.74b |
| Other Expenses | kr4.26b |
| Earnings | kr480.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 18, 2024
| Earnings per share (EPS) | 1.76 |
| Gross Margin | 43.13% |
| Net Profit Margin | 4.37% |
| Debt/Equity Ratio | 57.5% |
How did ARJOBS perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield51%
Payout RatioDoes ARJOBS pay a reliable dividends?
See ARJOBS dividend history and benchmarks| Arjo dividend dates | |
|---|---|
| Ex Dividend Date | Apr 19 2024 |
| Dividend Pay Date | Apr 25 2024 |
| Days until Ex dividend | 28 days |
| Days until Dividend pay date | 22 days |
Does ARJOBS pay a reliable dividends?
See ARJOBS dividend history and benchmarks